glp-1 heart disease Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action glp 1 effects on heart
Description
Herein, we highlight the key scientific advances in utilising incretins for the treatment of obesity and, potentially, non-alcoholic fatty liver disease (NAFLD)
Discover online weight management program, with smart scale, expert coaches, and personalized plans.
Who are the hidden champions
GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs
Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.
